These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24836982)

  • 1. Sample size calculation for count data in comparative clinical trials with nonuniform patient accrual and early dropout.
    Li H; Wang L; Wei L; Quan H
    J Biopharm Stat; 2015; 25(1):1-15. PubMed ID: 24836982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of time-to-event data with nonuniform patient entry and loss to follow-up under a two-stage seamless adaptive design with weibull distribution.
    Lu Q; Tse SK; Chow SC; Lin M
    J Biopharm Stat; 2012; 22(4):773-84. PubMed ID: 22651114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stochastic modeling and prediction for accrual in clinical trials.
    Zhang X; Long Q
    Stat Med; 2010 Mar; 29(6):649-58. PubMed ID: 20082363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI-based clinical trials in relapsing-remitting MS: new sample size calculations based on a longitudinal model.
    Altman RM; Petkau AJ; Vrecko D; Smith A
    Mult Scler; 2012 Nov; 18(11):1600-8. PubMed ID: 22495948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subject allocation and study curtailment for fixed event comparative Poisson trials.
    Hoover DR
    Stat Med; 2004 Apr; 23(8):1229-45. PubMed ID: 15083480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Joint monitoring and prediction of accrual and event times in clinical trials.
    Zhang X; Long Q
    Biom J; 2012 Nov; 54(6):735-49. PubMed ID: 22907686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A two-stage analysis of repeated measurements with dropouts and/or intermittent missing data.
    Overall JE; Tonidandel S
    J Clin Psychol; 2006 Mar; 62(3):285-91. PubMed ID: 16299743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample size calculation based on efficient unconditional tests for clinical trials with historical controls.
    Shan G; Moonie S; Shen J
    J Biopharm Stat; 2016; 26(2):240-9. PubMed ID: 25551261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sample size calculation for the weighted rank statistics with paired survival data.
    Jung SH
    Stat Med; 2008 Jul; 27(17):3350-65. PubMed ID: 18205148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sample size calculations for comparative clinical trials with over-dispersed Poisson process data.
    Matsui S
    Stat Med; 2005 May; 24(9):1339-56. PubMed ID: 15568188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robustness of methods for blinded sample size re-estimation with overdispersed count data.
    Schneider S; Schmidli H; Friede T
    Stat Med; 2013 Sep; 32(21):3623-35. PubMed ID: 23595966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On statistical tests for homogeneity of two bivariate zero-inflated Poisson populations.
    Yuen HK; Chow SC; Tse SK
    J Biopharm Stat; 2015; 25(1):44-53. PubMed ID: 24837140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Power and sample size for randomized phase III survival trials under the Weibull model.
    Wu J
    J Biopharm Stat; 2015; 25(1):16-28. PubMed ID: 24895942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sample size calculation for comparing two negative binomial rates.
    Zhu H; Lakkis H
    Stat Med; 2014 Feb; 33(3):376-87. PubMed ID: 24038204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A note on sample size calculation based on propensity analysis in nonrandomized trials.
    Jung SH; Chow SC; Chi EM
    J Biopharm Stat; 2007; 17(1):35-41; discussion 43. PubMed ID: 17219754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sample size/power calculations for population pharmacodynamic experiments involving repeated-count measurements.
    Ogungbenro K; Aarons L
    J Biopharm Stat; 2010 Sep; 20(5):1026-42. PubMed ID: 20721789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some Issues of Sample Size Calculation for Time-to-Event Endpoints Using the Freedman and Schoenfeld Formulas.
    Abel UR; Jensen K; Karapanagiotou-Schenkel I; Kieser M
    J Biopharm Stat; 2015; 25(6):1285-311. PubMed ID: 25629760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample size calculation for clinical trials with correlated count measurements based on the negative binomial distribution.
    Li D; Zhang S; Cao J
    Stat Med; 2019 Dec; 38(28):5413-5427. PubMed ID: 31652010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple-arm superiority and non-inferiority designs with various endpoints.
    Chang M
    Pharm Stat; 2007; 6(1):43-52. PubMed ID: 17323311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling the patient accrual with truncated Gaussian mixture distribution for the accurate estimation of sample size in survival trials.
    Hu H; Wang L; Li C; Ge W; Wu K; Xia J
    Stat Methods Med Res; 2020 Oct; 29(10):2972-2987. PubMed ID: 32281472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.